Palomero J, Galvao V, Creus I, Lostes J, Aylagas M, Marin-Bayo A
Immunooncol Technol. 2025; 25:101030.
PMID: 39911162
PMC: 11791158.
DOI: 10.1016/j.iotech.2024.101030.
Guille A, Adelaide J, Finetti P, Andre F, Birnbaum D, Mamessier E
Brief Bioinform. 2025; 26(1).
PMID: 39828270
PMC: 11790059.
DOI: 10.1093/bib/bbae697.
Koroglu M, Bilguvar K
Methods Mol Biol. 2025; 2889:207-233.
PMID: 39745615
DOI: 10.1007/978-1-0716-4322-8_15.
Agostini M, Giacobbi E, Servadei F, Bishof J, Funke L, Sica G
Biol Direct. 2024; 19(1):146.
PMID: 39741346
PMC: 11686862.
DOI: 10.1186/s13062-024-00492-z.
Li H, Meng L, Wang H, Cui L, Sheng H, Zhao P
Brief Bioinform. 2024; 26(1).
PMID: 39737564
PMC: 11684894.
DOI: 10.1093/bib/bbae677.
Contributing factors to the oxidation-induced mutational landscape in human cells.
Cordero C, Mehta K, Weaver T, Ling J, Freudenthal B, Cortez D
Nat Commun. 2024; 15(1):10722.
PMID: 39715760
PMC: 11666792.
DOI: 10.1038/s41467-024-55497-z.
CapHLA: a comprehensive tool to predict peptide presentation and binding to HLA class I and class II.
Chang Y, Wu L
Brief Bioinform. 2024; 26(1).
PMID: 39688477
PMC: 11650860.
DOI: 10.1093/bib/bbae595.
Integrated immunogenomic analyses of high-grade serous ovarian cancer reveal vulnerability to combination immunotherapy.
Gronauer R, Madersbacher L, Monfort-Lanzas P, Floriani G, Sprung S, Zeimet A
Front Immunol. 2024; 15:1489235.
PMID: 39669575
PMC: 11634877.
DOI: 10.3389/fimmu.2024.1489235.
Auxiliary diagnosis of primary bone tumors based on Machine learning model.
Deng S, Huang Y, Li C, Qian J, Wang X
J Bone Oncol. 2024; 49:100648.
PMID: 39624676
PMC: 11609325.
DOI: 10.1016/j.jbo.2024.100648.
Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial.
Li R, Villa N, Yu X, Johnson J, Borjas G, Dhillon J
Nat Med. 2024; 31(1):176-188.
PMID: 39521884
DOI: 10.1038/s41591-024-03324-9.
Genomic and transcriptomic landscape of human gastrointestinal stromal tumors.
Xie F, Luo S, Liu D, Lu X, Wang M, Liu X
Nat Commun. 2024; 15(1):9495.
PMID: 39489749
PMC: 11532483.
DOI: 10.1038/s41467-024-53821-1.
Widespread mutagenesis and chromosomal instability shape somatic genomes in systemic sclerosis.
Vijayraghavan S, Blouin T, McCollum J, Porcher L, Virard F, Zavadil J
Nat Commun. 2024; 15(1):8889.
PMID: 39406724
PMC: 11480385.
DOI: 10.1038/s41467-024-53332-z.
Metapipeline-DNA: A Comprehensive Germline & Somatic Genomics Nextflow Pipeline.
Patel Y, Zhu C, Yamaguchi T, Wang N, Wang N, Wiltsie N
bioRxiv. 2024; .
PMID: 39282325
PMC: 11398472.
DOI: 10.1101/2024.09.04.611267.
DeepSomatic: Accurate somatic small variant discovery for multiple sequencing technologies.
Park J, Cook D, Chang P, Kolesnikov A, Brambrink L, Mier J
bioRxiv. 2024; .
PMID: 39229187
PMC: 11370364.
DOI: 10.1101/2024.08.16.608331.
Divergent Evolution in Bilateral Prostate Cancer: a Case Study.
Haas R, Patel Y, Liu L, Huang R, Weiner A, Yamaguchi T
medRxiv. 2024; .
PMID: 39228741
PMC: 11370525.
DOI: 10.1101/2024.08.22.24312320.
ONCOLINER: A new solution for monitoring, improving, and harmonizing somatic variant calling across genomic oncology centers.
Martin R, Gaitan N, Jarlier F, Feuerbach L, de Soyres H, Arbones M
Cell Genom. 2024; 4(9):100639.
PMID: 39216474
PMC: 11480849.
DOI: 10.1016/j.xgen.2024.100639.
The Proteogenomics of Prostate Cancer Radioresistance.
Haas R, Frame G, Khan S, Neilsen B, Hong B, Yeo C
Cancer Res Commun. 2024; 4(9):2463-2479.
PMID: 39166898
PMC: 11411600.
DOI: 10.1158/2767-9764.CRC-24-0292.
A comprehensive molecular characterization of a claudin-low luminal B breast tumor.
Giovannini S, Smirnov A, Concetti L, Scimeca M, Mauriello A, Bischof J
Biol Direct. 2024; 19(1):66.
PMID: 39152485
PMC: 11328405.
DOI: 10.1186/s13062-024-00482-1.
A Novel Affordable and Reliable Framework for Accurate Detection and Comprehensive Analysis of Somatic Mutations in Cancer.
Atzeni R, Massidda M, Pieroni E, Rallo V, Pisu M, Angius A
Int J Mol Sci. 2024; 25(15).
PMID: 39125613
PMC: 11311285.
DOI: 10.3390/ijms25158044.
A Comparative Genomic Analysis of Parathyroid Adenomas and Carcinomas Harboring Heterozygous Germline CDC73 Mutations.
Li Y, Simonds W, Chen H
J Clin Endocrinol Metab. 2024; 110(2):429-440.
PMID: 39044678
PMC: 11747674.
DOI: 10.1210/clinem/dgae506.